Cardiovascular care and prevention don’t have an information problem. New guidelines, therapies, imaging capabilities and increasingly sophisticated technology are at every clinician’s disposal.
The challenge is putting the unprecedented volume of evidence and innovation into practice, says Viet Le, PA-C, DMSc, an associate professor of research and a preventive cardiology PA at Intermountain Health in Salt Lake City, Utah.
“We’re not lacking information, but we’re all trying to navigate how we pragmatically and practically do this. How do we implement what we just heard?” says Le.
As we enter into fall conference season, Le shares his thoughts on how to explore the latest advances in cardiovascular disease to ensure what clinicians learn has practical applications.
For Le, the value from any particular conference comes from focusing not only on what’s new in cardiovascular care but also on how to make the latest evidence achievable in everyday care while working within large health systems.
Here are four themes Le brought home from ASPC 2026 and as he prepares for upcoming fall conferences
Emphasize implementation of what clinicians already know
New cardiovascular guidance improves outcomes only if clinicians and health systems can put it into practice.
Rather than conversations that focus solely on new evidence or high-level recommendations, Le says seeking out sessions and conversations that focus on what clinicians can change when they return to practice.
“If you’re looking to level up quickly in the preventive cardiology space, conferences like ASPC allow clinicians to think about how do I now implement this Monday after?”
Advances in cardiovascular-kidney-metabolic (CKM) care, hypertension, lipid management, imaging, medications and other areas give clinicians more opportunities to identify risk and intervene earlier. But knowing the evidence and consistently delivering evidence-based care are different challenges.
“You should come home that next week and be able to start implementing things. That’s what a conference should be about,” says Le.
Prevention can’t rest on individual clinicians
While individual champions can make an impact in their area of practice, implementing new guidelines, evidence and technology is bigger than any one provider.
The message for health system leaders attending fall conferences needs to be about providing the infrastructure, incentives and workflows necessary for clinicians to effectively implement new guidelines and evidence-based practices, says Le.
That’s increasingly true as cardiovascular prevention expands beyond a single disease, specialty or risk factor.
For example, cardiovascular, kidney and metabolic health are all interconnected, which requires providers to think across traditional specialty boundaries for each patient. “You cannot work in silos. If you see someone with hypertension, they’re at risk or have kidney disease, metabolic disease, in addition to heart disease and stroke,” says Le, who is a co-director of Intermountain Health’s preventive cardiology clinic, and in the last five years, has helped build a cardiovascular kidney metabolic clinic as well.
Support for better coordinated care requires system-wide support, both from the institutions where providers practice and from the U.S. healthcare system overall. “Clinicians want to do right, but they work within systems built around competing demands and incentives. “Prevention is everyone’s problem, and systems need to buy into that,” says Le.
Technology can make the right care easier to deliver
If bureaucracy is part of the implementation problem, technology –– especially AI –– could become part of the solution.
Rather than focusing on whether AI will replace clinicians, fall conference conversations should emphasize how the tools can reduce the burden of finding and interpreting an ever-growing amount of clinical information.
For example, Le sees an opportunity for AI to surface relevant information within a medical record or from a scan and present it to a clinician at the point of care. The goal isn’t to remove the clinician from decision-making but to reduce the cognitive work required before that decision can be made.
This is especially helpful for most clinicians who have little time allotted to each appointment. “If you have a large language model that pulls up information before I enter into the chart, that’s helpful,” says Le.
AI and other emerging technologies can make it easier for clinicians to stay on top of the latest evidence, which is changing faster than ever, supporting evidence-based implementation in practice.
Hypertension shows what the implementation gap looks like in practice
When it comes to conversations about hypertension, Le hopes to see an emphasis on resistant hypertension and newer approaches to hypertension treatment. But before clinicians can identify resistant hypertension or determine whether a medication is working, they need reliable blood pressure information on the effectiveness of each therapy.
“We’re not treating to less than 130 over 80, but you can’t make a diagnosis of resistant hypertension unless you’re treating regular hypertension. Only after two or three meds later, can you determine if someone has resistant hypertension,” says Le.
Ambulatory blood pressure monitoring (ABPM) provides information that single clinic measurements fail to capture. Le, who recognizes that 24-hour ABPM is the gold standard, faces barriers to ordering the test for patients within existing workflows.
Beyond device availability, every test at Intermountain Health requires a specifically trained ABPM reader. With so few people available for that work, the reading process becomes a bottleneck.
“If that’s the rate-limiting step, and you only have one, maybe two readers, access becomes difficult to scale,” he says.
Instead, Le typically recommends home blood pressure monitoring when 24-hour monitoring is not feasible for his patients. He considers those measurements preferable to relying only on a clinic reading, but he is clear about the trade-off.
“It’s not as good as an ABPM,” says Le.
Le’s experience with blood pressure monitoring captures the broader challenge of implementing evidence and guidelines.
That’s precisely the kind of gap where Le sees an opportunity for technology like Biobeat. “Certainly, a lot of interpreting ABPM can be automated,” he says.
Biobeat’s 24-hour cuffless devices make ABPM easy for clinicians to implement and include an automated, detailed report delivered directly to the provider and simple enough for a patient to interpret.
Turning cardiovascular prevention into everyday practice
The resounding message from Le as we approach fall conference season, is that innovation is effective only when it gets through the last mile of healthcare delivery.
To turn evidence into action, any new technology, workflow or new model of care must come without unnecessary barriers for patients and care teams. Hypertension offers an important opportunity to put that philosophy into practice.
Biobeat addresses the practical barriers surrounding 24-hour blood pressure monitoring head-on.
- A comfortable, cuffless chest sensor collects ABPM over 24 hours without repeated cuff inflation
- Clinicians receive an easy-to-read report, including day and nighttime blood pressure information
- The disposable device is easy to deploy on every patient who needs it
- Covered by most commercial insurance and Medicare
By improving workflow and scalability, Biobeat shows what implementing cardiovascular care with evidence-based guidelines can look like.
See cuffless ABPM for at a fall conference
We’ll be at several cardiovascular conferences all across the U.S. this fall. Stop by our booth, schedule a demo or join a conference panel.
Click here to see our full schedule
AHA: Join our panel or dinner to hear how physicians are integrating cuffless ABPM into their practice workflow:
- PANEL: Researchers will share new clinical data from a study of 214 hypertensive patients
- DINNER: With Dr. Omar Al Dhaybi, director of cardiology hypertension at the Mount Sinai Fuster Heart Hospital
ASN: Researchers will share new evidence on real-world outcomes for hypertension management
- BOOTH: Stop by to see new clinical data from a study of 214 hypertensive patients
- DINNER: With Andrew M. Freeman MD, FACC, FACP, National Jewish Health in Denver, CO.
Click here to schedule a quick demo or find out how to meet us at a fall conference.